Clustering of metabolic syndrome components in a middle eastern diabetic and non-diabetic population

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Esteghamati, Alireza ^a   Zandieh, Ali ^a   Khalilzadeh, Omid ^a   Meysamie, Alipasha ^b   Ashraf, Haleh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE EAST; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 77954493953     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-36     Document Type: Article

References (35)

1. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. SM Grundy B Hansen SC Smith JI Cleeman RA Kahn, Circulation 2004 109 4 551 556 10.1161/01.CIR.0000112379.88385.67 14757684
2. Components of the "metabolic syndrome" and incidence of type 2 diabetes. RL Hanson G Imperatore PH Bennett WC Knowler, Diabetes 2002 51 10 3120 3127 10.2337/diabetes.51.10.3120 12351457
3. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. JB Meigs, Am J Epidemiol 2000 152 10 908 911 10.1093/aje/152.10.908 11092432
4. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. E Ferrannini, Endocr Rev 1998 19 4 477 490 10.1210/er.19.4.477 9715376
5. How many components for the metabolic syndrome? Results of exploratory factor analysis in the FIBAR study. E Mannucci M Monami CM Rotella, Nutr Metab Cardiovasc Dis 2007 17 10 719 726 10.1016/j.numecd.2006.09.003 17387006
6. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. M Pyorala H Miettinen P Halonen M Laakso K Pyorala, Arterioscler Thromb Vasc Biol 2000 20 2 538 544 10669654
7. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. HM Lakka DE Laaksonen TA Lakka LK Niskanen E Kumpusalo J Tuomilehto JT Salonen, JAMA 2002 288 21 2709 2716 10.1001/jama.288.21.2709 12460094
8. Leptin and other components of the Metabolic Syndrome in Mauritius - a factor analysis. AM Hodge EJ Boyko M de Courten PZ Zimmet P Chitson J Tuomilehto KG Alberti, Int J Obes Relat Metab Disord 2001 25 1 126 131 10.1038/sj.ijo.0801522 11244468
9. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. AJ Hanley A Festa RB D'Agostino LE Wagenknecht PJ Savage RP Tracy MF Saad SM Haffner, Diabetes 2004 53 7 1773 1781 10.2337/diabetes.53.7.1773 15220201
10. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. JY Oh YS Hong YA Sung E Barrett-Connor, Diabetes Care 2004 27 8 2027 2032 10.2337/diacare.27.8.2027 15277435
11. Heritability of multivariate factors of the metabolic syndrome in nondiabetic Japanese americans. MA Austin KL Edwards MJ McNeely WL Chandler DL Leonetti PJ Talmud SE Humphries WY Fujimoto, Diabetes 2004 53 4 1166 1169 10.2337/diabetes.53.4.1166 15047637
12. Factor analysis of metabolic syndrome components in obese women. CL Lafortuna F Adorni F Agosti A Sartorio, Nutr Metab Cardiovasc Dis 2008 18 3 233 241 10.1016/j.numecd.2007.02.002 17600693
13. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. PA Sakkinen P Wahl M Cushman MR Lewis RP Tracy, Am J Epidemiol 2000 152 10 897 907 10.1093/aje/152.10.897 11092431
14. Racial differences in the relation between blood pressure and insulin resistance. MF Saad S Lillioja BL Nyomba C Castillo R Ferraro M De Gregorio E Ravussin WC Knowler PH Bennett BV Howard, et al. N Engl J Med 1991 324 11 733 739 1997839
15. (Mis)use of factor analysis in the study of insulin resistance syndrome. DA Lawlor S Ebrahim M May G Davey Smith, Am J Epidemiol 2004 159 11 1013 1018 10.1093/aje/kwh150 15155285
16. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. U Salmenniemi E Ruotsalainen J Pihlajamaki I Vauhkonen S Kainulainen K Punnonen E Vanninen M Laakso, Circulation 2004 110 25 3842 3848 10.1161/01.CIR.0000150391.38660.9B 15596567
17. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [article online]. 2006 http://www.idf.org/webdata/ docs/IDF-Meta-def-final.pdf Accessed August 10, 2009
18. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in Iranian adults: results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). A Esteghamati M Abbasi A Rashidi A Meysamie O Khalilzadeh M Haghazali F Asgari M Nakhjavani, Diabet Med 2009 26 7 745 746 10.1111/j.1464-5491.2009.02756.x 19573127
19. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825
20. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2008 31 Suppl 1 55 60 18165338
21. Follow-up report on the diagnosis of diabetes mellitus. S Genuth KG Alberti P Bennett J Buse R Defronzo R Kahn J Kitzmiller WC Knowler H Lebovitz A Lernmark, et al. Diabetes Care 2003 26 11 3160 3167 10.2337/diacare.26.11.3160 14578255
22. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: the First National Survey of Risk Factors for Non-Communicable Diseases of Iran. Ministry of Health Programs Reports, Ministry of Health and Medical Education, Tehran, Iran 2005
23. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. M Pladevall B Singal LK Williams C Brotons H Guyer J Sadurni C Falces M Serrano-Rios R Gabriel JE Shaw, et al. Diabetes Care 2006 29 1 113 122 10.2337/diacare.29.01.06.dc05-0862 16373906
24. Visceral fat and insulin resistance - causative or correlative? KN Frayn, Br J Nutr 2000 83 Suppl 1 71 77 10889795
25. Use and abuse of HOMA modeling. TM Wallace JC Levy DR Matthews, Diabetes Care 2004 27 6 1487 1495 10.2337/diacare.27.6.1487 15161807
26. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. A Katsuki Y Sumida EC Gabazza S Murashima M Furuta R Araki-Sasaki Y Hori Y Yano Y Adachi, Diabetes Care 2001 24 2 362 365 10.2337/diacare.24.2.362 11213893
27. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. ES Kang YS Yun SW Park HJ Kim CW Ahn YD Song BS Cha SK Lim KR Kim HC Lee, Metabolism 2005 54 2 206 211 10.1016/j.metabol.2004.08.014 15690315
28. Factor analysis: an applied approach. EE Cureton RB D'Agostino, Hillsdale, NJ: Lawrence Erlbaum Associates 1983
29. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. BJ Shen JF Todaro R Niaura JM McCaffery J Zhang A Spiro KD Ward, Am J Epidemiol 2003 157 8 701 711 10.1093/aje/kwg045 12697574
30. Insulin resistance and triglyceride/HDLc index are associated with coronary artery disease. MC Bertoluci AS Quadros R Sarmento-Leite BD Schaan, Diabetol Metab Syndr 2010 2 11 10.1186/1758-5996-2-11 20181078
31. Dissecting the role of insulin resistance in the metabolic syndrome. JT Haas SB Biddinger, Curr Opin Lipidol 2009 20 3 206 210 10.1097/MOL. 0b013e32832b2024 19421055
32. Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus. T Hayashi S Takai C Yamashita, Curr Vasc Pharmacol 2010 1 20394107
33. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. G Grassi F Arenare F Quarti-Trevano G Seravalle G Mancia, Prog Cardiovasc Dis 2009 52 1 31 37 10.1016/j.pcad.2009.05.007 19615491
34. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. HD Sesso MJ Stampfer B Rosner CH Hennekens JM Gaziano JE Manson RJ Glynn, Hypertension 2000 36 5 801 807 11082146
35. Cutoff values for normal anthropometric variables in asian Indian adults. C Snehalatha V Viswanathan A Ramachandran, Diabetes Care 2003 26 5 1380 1384 10.2337/diacare.26.5.1380 12716792